Ginger Blackmon, PharmD

Articles by Ginger Blackmon, PharmD

AI-generated image of bispecific antibodies -- Image credit: ProArt Studios | stock.adobe.com

The Term 'Bispecific Antibody' Is No Longer Enough

ByDaisy Doan, PharmD,Lauren Carpenter, PharmD,Tahsin Imam, PharmD,Nikki West, PharmD, BCOP,Ginger Blackmon, PharmD,Kelly M. Brunk, PharmD, BCOP

June 16th 2025

Bispecific therapies require clearer terminology to improve safety and communication.

From Workflow Integration to Patient Outcomes: The Expanding Role of PQIs

ByGinger Blackmon, PharmD,Alana Hippensteele, Lead Editor

April 24th 2025

Ginger Blackmon, PharmD, explains how NCODA’s Positive Quality Interventions (PQIs) help improve oncology care by guiding best practices, supporting teamwork, and streamlining workflows.

Latest Updated Articles

From Workflow Integration to Patient Outcomes: The Expanding Role of PQIs
Published: April 24th 2025 | Updated:
The Term 'Bispecific Antibody' Is No Longer Enough
Published: June 16th 2025 | Updated:

Ginger Blackmon, PharmD

Articles by Ginger Blackmon, PharmD

The Term 'Bispecific Antibody' Is No Longer Enough

From Workflow Integration to Patient Outcomes: The Expanding Role of PQIs

Latest Updated Articles

Trending on Pharmacy Times

Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk

Pharmacists Key to Counseling and Monitoring Patients Transitioning to Low-Sodium Oxybate